Gastrointestinal Stromal Tumor
📧 Sign up to get email alerts when something new happens for Gastrointestinal Stromal Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-11-21Clinical Trial Update: Study of Imatinib and Peginterferon α-2b in Gastrointestinal Stromal Tumor (GIST) Patients [Phase 2]
Phase 2 study evaluating imatinib in combination with peginterferon alfa-2b in patients with gastrointestinal stromal tumors. The trial was …
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma [Phase 1, Phase 2]
Phase 1/2 trial update of STI571 (imatinib) in patients with recurrent or refractory soft tissue sarcoma; the study status is reported as co…
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: Imatinib Mesylate With or Without Surgery in Treating Patients With Metastatic Gastrointestinal Stromal Tumor That is Responding to Imatinib Mesylate [Phase 3]
Phase 3 trial evaluating imatinib mesylate with or without surgery for metastatic gastrointestinal stromal tumor that responds to imatinib h…
-
CLINICAL_TRIALS trial_result · 2012-08-02Clinical Trial Update: Gastrointestinal Stromal Tumors (GIST) Registry
Clinical trial update for the Gastrointestinal stromal tumor (GIST) Registry sponsored by MD Anderson Cancer Center shows the study status a…
-
CLINICAL_TRIALS trial_result · 2012-07-18Clinical Trial Update: Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma [Phase 2]
A Phase 2 study evaluating brostallicin in patients with locally advanced or metastatic soft tissue sarcoma has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-07-16Clinical Trial Update: The Biological Activity of Cediranib (AZD2171) in Gastro-Intestinal Stromal Tumours(GIST). [Phase 2]
Phase 2 study evaluating the biological activity of cediranib (AZD2171) in gastrointestinal stromal tumors and related soft tissue sarcomas;…
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction [Phase 1, Phase 2]
This entry reports completion of a Phase 1/2 trial evaluating endoscopic placement of a metal stent to treat cancer-related bowel obstructio…
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery [Phase 2]
Phase 2 trial evaluating octreotide as palliation for cancer-related bowel obstruction that cannot be removed by surgery; the study has comp…
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction [Phase 1, Phase 2]
This multi-phase trial evaluated endoscopic placement of metal stents to treat cancer-related duodenal obstruction in patients with several …
-
CLINICAL_TRIALS trial_result · 2012-03-08Clinical Trial Update: Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor [Phase 2]
Phase 2 trial of imatinib mesylate in locally advanced gastrointestinal stromal tumor has completed. Trial results are not detailed in the p…
-
CLINICAL_TRIALS trial_result · 2012-01-06Clinical Trial Update: Study on the Evolution of Genes Mutation Related With Gastrointestinal Stromal Tumors
A completed clinical trial from Guangxi Medical University analyzes full gene sequences of c-KIT, PDGFRA, and DOG1 to characterize mutations…
-
CLINICAL_TRIALS trial_result · 2011-12-30Clinical Trial Update: Study Comparing 12 Months Versus 36 Months of Imatinib in the Treatment of Gastrointestinal Stromal Tumor (GIST) [Phase 3]
A Phase 3 study compares 12 months versus 36 months of imatinib therapy in patients with gastrointestinal stromal tumor (GIST) to determine …
-
CLINICAL_TRIALS trial_result · 2011-11-16Clinical Trial Update: Imatinib Mesylate and Sunitinib in Treating Patients With Gastrointestinal Stromal Tumors [Phase 1]
Phase 1 trial evaluating imatinib mesylate and sunitinib for gastrointestinal stromal tumors has been terminated.
-
CLINICAL_TRIALS trial_result · 2011-11-02Clinical Trial Update: Evaluation of Cognitive Function of Patients With Sunitinib or Sorafenib
The document reports a completed clinical trial evaluating cognitive function in patients treated with sunitinib or sorafenib for metastatic…
-
CLINICAL_TRIALS trial_result · 2011-09-16Clinical Trial Update: Study to the Optimal Duration of Therapy With Oral Angiogenesis Inhibitors [Phase 4]
This Phase 4 clinical trial update discusses evaluating the optimal duration of therapy with oral angiogenesis inhibitors in patients with r…
-
CLINICAL_TRIALS trial_result · 2011-08-08Clinical Trial Update: Preoperative and Postoperative Imatinib Mesylate Study in Patients With c-Kit Positive GIST [Phase 2]
Phase 2 study of preoperative and postoperative imatinib mesylate for c-KIT positive gastrointestinal stromal tumors has completed.
-
CLINICAL_TRIALS trial_result · 2011-07-01Clinical Trial Update: A Prospective, Multicenter Study on Best Clinical Use of Imatinib in the Advanced Gastrointestinal Stromal Tumors [Phase 2]
A prospective, multicenter Phase 2 study evaluates the best clinical use of imatinib in advanced gastrointestinal stromal tumors. The trial …
-
CLINICAL_TRIALS trial_result · 2011-04-06Clinical Trial Update: Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer [Phase 2]
Phase 2 trial evaluating combination chemotherapy in patients with Stage III ovarian epithelial cancer or various gastrointestinal cancers. …
-
CLINICAL_TRIALS trial_result · 2011-03-29Clinical Trial Update: Impact of the Inhibitors of Tyrosine Kinase on the Male Fertility [NA]
This clinical trial update assesses how tyrosine kinase inhibitors affect male fertility in patients with chronic myeloid leukemia or gastro…
-
CLINICAL_TRIALS trial_result · 2010-12-31Clinical Trial Update: Safety And Effectiveness Of Daily Dosing With Sunitinib Or Imatinib In Patients With Gastrointestinal Stromal Tumors [Phase 3]
Phase 3 trial comparing daily sunitinib versus imatinib in patients with gastrointestinal stromal tumors has been terminated with results po…
-
CLINICAL_TRIALS trial_result · 2010-12-28Clinical Trial Update: Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor [Phase 1]
A Phase 1 trial evaluated a vaccine therapy in combination with sargramostim for patients with sarcoma or brain/central nervous system tumor…
-
CLINICAL_TRIALS trial_result · 2010-05-27Clinical Trial Update: PTK787/ZK222584 in the Treatment of Metastatic Gastrointestinal Stromal Tumors Resistant to Imatinib [Phase 2]
The document describes the completion of a Phase 2 clinical trial of PTK787/ZK222584 for metastatic gastrointestinal stromal tumors resistan…
-
CLINICAL_TRIALS trial_result · 2010-03-18Clinical Trial Update: Study of the Immunoresponse in Patients Treated With a Tyrosine Kinase Inhibitor
A completed clinical trial update investigating immunoresponse in patients treated with a tyrosine kinase inhibitor for renal cell carcinoma…
-
CLINICAL_TRIALS trial_result · 2010-03-10Clinical Trial Update: Follow-up of the Natural Course of the Small EUS-suspected Gastric Gastointestinal Stromal Tumors
Clinical trial NCT01084460, sponsored by National Taiwan University Hospital, completed follow-up to observe the natural course of small EUS…
-
CLINICAL_TRIALS trial_result · 2009-11-13Clinical Trial Update: A Phase I/II Study of Sunitinib Malate (SU011248) In Patients With Gastrointestinal Stromal Tumor (GIST) [Phase 1, Phase 2]
Phase I/II study of sunitinib malate (SU011248) in patients with gastrointestinal stromal tumors has completed with results posted in 2009.